Recruiting IgA Nephropathy Studies in San Bernardino
About IgA Nephropathy Clinical Trials in San Bernardino
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 1 iga nephropathy clinical trials recruiting participants in San Bernardino, CALIFORNIA. These studies are seeking a combined 510 participants. Research is being sponsored by Alexion Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in San Bernardino — FAQ
Are there iga nephropathy clinical trials in San Bernardino?
Yes, there are 1 iga nephropathy clinical trials currently recruiting in San Bernardino, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Bernardino?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Bernardino research site will contact you about next steps.
Are clinical trials in San Bernardino free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Bernardino studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 1 active trials in San Bernardino are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated March 2, 2026 from ClinicalTrials.gov